PHARMOS CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
PHARMOS CORP had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $0.07 per share as of 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2012-11-19
- 2012-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $0.07.
- 2012-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $0.06.
- 2011-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $0.09.
- 2011-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $0.05.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2012-09-30 | $0.07 10-Q · filed 2012-11-19 |
| 2012-06-30 | $0.06 10-Q · filed 2012-07-30 |
| 2011-09-30 | $0.09 10-Q · filed 2012-11-19 |
| 2011-06-30 | $0.05 10-Q · filed 2012-07-30 |